EE694 The Cost-Effectiveness of Targeted-Release Form (TRF)-Budesonide for the Treatment of Adult Population With Immunoglobulin A Nephropathy (IgAN) in Greece
Abstract
Authors
Katerina Vellopoulou Stylianos Ravanidis Konstantinos Kipentzoglou Yanna Sotirakou Zhuro Olga Joachim Vöhringer Panagiotis Koukoulommatis Vassilios Liakopoulos Smaragdi Marinaki Maria Stangkou Georgia Kourlaba